Staphylococcus aureus septic arthritis in patients on hemodialysis treatment

West J Med. 1995 Aug;163(2):128-32.

Abstract

We retrospectively reviewed hospital discharge diagnoses of septic arthritis over an 11-year period (1982 through 1992) at 3 medical centers; 11 episodes of septic arthritis were identified in patients on hemodialysis treatment. Of the 11 episodes, 9 were caused by Staphylococcus aureus; in 8 of 9, the blood cultures were positive for the organism and the infection was monoarticular. Concurrent infection of the dialysis access site occurred in 4 cases. Two patients died (22%). We postulate that repeated skin trauma and contact with health care personnel and facilities result in a high rate of nasal carriage of S aureus and, hence, an increased risk of bacteremia with its attendant complications such as septic arthritis. The use of mupirocin nasal ointment is reported to eradicate or suppress carriage in a high percentage of patients; some studies report that long-term suppressive therapy reduces the frequency of S aureus bacteremia.

Publication types

  • Case Reports

MeSH terms

  • Administration, Intranasal
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Antibiotic Prophylaxis
  • Arthritis, Infectious / etiology*
  • Arthritis, Infectious / microbiology
  • Arthritis, Infectious / prevention & control
  • Female
  • Humans
  • Male
  • Middle Aged
  • Mupirocin / administration & dosage
  • Renal Dialysis / adverse effects*
  • Risk Factors
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / prevention & control

Substances

  • Anti-Bacterial Agents
  • Mupirocin